Does MOGAMULIZUMAB-KPKC Cause Lymphopenia? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Lymphopenia have been filed in association with MOGAMULIZUMAB-KPKC. This represents 1.9% of all adverse event reports for MOGAMULIZUMAB-KPKC.
23
Reports of Lymphopenia with MOGAMULIZUMAB-KPKC
1.9%
of all MOGAMULIZUMAB-KPKC reports
2
Deaths
4
Hospitalizations
How Dangerous Is Lymphopenia From MOGAMULIZUMAB-KPKC?
Of the 23 reports, 2 (8.7%) resulted in death, 4 (17.4%) required hospitalization, and 1 (4.3%) were considered life-threatening.
Is Lymphopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOGAMULIZUMAB-KPKC. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does MOGAMULIZUMAB-KPKC Cause?
Rash (177)
Disease progression (107)
Drug eruption (62)
Pruritus (58)
Infusion related reaction (54)
Death (45)
Fatigue (44)
Chills (40)
Inappropriate schedule of product administration (39)
Pyrexia (39)
What Other Drugs Cause Lymphopenia?
FINGOLIMOD (1,515)
CYCLOPHOSPHAMIDE (952)
RITUXIMAB (932)
DEXAMETHASONE (814)
PREDNISONE (788)
DIMETHYL (598)
METHOTREXATE (549)
PREDNISOLONE (465)
TACROLIMUS (456)
MYCOPHENOLATE MOFETIL (453)
Which MOGAMULIZUMAB-KPKC Alternatives Have Lower Lymphopenia Risk?
MOGAMULIZUMAB-KPKC vs MOLNUPIRAVIR
MOGAMULIZUMAB-KPKC vs MOLSIDOMINE
MOGAMULIZUMAB-KPKC vs MOMELOTINIB
MOGAMULIZUMAB-KPKC vs MOMETASONE
MOGAMULIZUMAB-KPKC vs MOMETASONE FUROATE